Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.580
-0.066 (-10.20%)
At close: Dec 20, 2024, 4:00 PM
0.594
+0.014 (2.33%)
After-hours: Dec 20, 2024, 5:10 PM EST
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $4.13M in the quarter ending September 30, 2024, a decrease of -10.38%. This brings the company's revenue in the last twelve months to $17.68M, up 4.12% year-over-year. In the year 2023, Ekso Bionics Holdings had annual revenue of $18.28M with 41.57% growth.
Revenue (ttm)
$17.68M
Revenue Growth
+4.12%
P/S Ratio
0.58
Revenue / Employee
$245,583
Employees
72
Market Cap
12.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | 13.92M | 2.59M | 22.81% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cosmos Health | 56.04M |
STRATA Skin Sciences | 32.68M |
Marinus Pharmaceuticals | 31.47M |
Aspira Women's Health | 8.96M |
Kazia Therapeutics | 1.66M |
TherapeuticsMD | 1.60M |
Eterna Therapeutics | 598.00K |
AIM ImmunoTech | 190.00K |
EKSO News
- 4 weeks ago - Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19 - GlobeNewsWire
- 5 weeks ago - Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference - GlobeNewsWire
- 7 weeks ago - Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Ekso Bionics Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024 - GlobeNewsWire
- 4 months ago - Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - GlobeNewsWire
- 5 months ago - Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024 - GlobeNewsWire